Heart Warning Added to Pfizer Inc.s "Z-Pak" Antibiotic by FDA
3/13/2013
More...
|
Genmab, Inc., Roche Drug Reduces Damage to Heart Muscle During Angioplasty
3/11/2013
More...
|
Bristol-Myers Squibb Company, Pfizer Inc. Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats
1/23/2013
More...
|
Boehringer Ingelheim Corporation Ends Phase 2 Trial of Dabigatran in Mechanical Valve Patients
12/13/2012
More...
|
GlaxoSmithKline's High-Dose Zofran Pulled From Market
12/7/2012
More...
|
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal
11/28/2012
More...
|
Novo Nordisk A/S's Insulin Tresiba Has Heart Safety Risks, FDA Says
11/6/2012
More...
|
Omthera Pharmaceuticals, Inc. Blasts Competitor Out of the Way as Omega-3 Makes Headlights in Phase 3 Study
11/6/2012
More...
|
Amgen's Risky Heart Drug Gamble
11/6/2012
More...
|
Cardiome Pharma Corp. Says Merck & Co., Inc. Pulls Out of Heart Drug Deal
9/26/2012
More...
|
Amarin Corporation PLC Still Awaits FDA OK for Heart Drug
9/11/2012
More...
|
Resverlogix Corporation Rises on Heart Drug Study Results
8/28/2012
More...
|
Daiichi Sankyo, Inc., Eli Lilly and Company Say Heart Drug Effient Fails to Meet Goal in a Phase III Trial
8/27/2012
More...
|
Merck & Co., Inc. on Track to Seek Approval for Two Heart Drugs in ’13
8/27/2012
More...
|
Amarin Corporation PLC's Fish Oil Drug Wins FDA Approval to Treat High Blood Fats
7/30/2012
More...
|